Urogenital Neoplasms  >>  U3-1565  >>  Phase 1
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
U3-1565 / Daiichi Sankyo
NCT01290471: Study to Assess the Safety and Tolerability of U3-1565 in Subjects With Advanced Solid Malignant Tumors

Completed
1
36
US
U3-1565
Daiichi Sankyo, Inc.
Advanced Solid Malignant Tumors, Advanced Ovarian Cancer
01/13
01/13

Download Options